Judge: Teva not liable for Oxycontin patent violation

Share this article:

Generics and branded drugmaker Teva took a swing and won against painkiller company Purdue Pharma.

Bloomberg reports that Purdue, whose name is synonymous with Oxycontin, lost a legal battle in which it asserted that Teva's generic violated multiple patents.

US District Judge Sidney Stein agreed that Teva overstepped three patents, but said the “obvious” nature of the patents meant he was not going to hold the company liable.

Purdue told Bloomberg it will appeal the decision.

Share this article:

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.